Ten strains of a hitherto undescribed catalase-negative, facultatively anaerobic, coryneform bacterium were isolated or collected by workers at three European clinical bacteriology laboratories or reference centers. These strains were isolated from humans, and most came from abscess material. Biochemical and chemotaxonomic characterization revealed that the strains belonged to the genus Actinomyces. The phenotypic features of the 10 strains were incompatible with the descriptions of the previously established Actinomyces species. A comparative 16s rRNA gene sequence analysis demonstrated that the previously undescribed strains constitute a new line in the genus Actinomyces. The name Actinomyces europaeus sp. nov. is proposed for these clinical isolates. The type strain is CCUG 32789A.
In the 1 9 9 0~~ there has been increasing recognition of the importance of coryneform bacteria (i.e., aerobic, asporogenous, irregular, non-partially acid-fast, gram-positive rods) as opportunistic human pathogens (8) . As a result of increased medical interest in such organisms, combined with intensified taxonomic investigations, a number of new coryneform and related high-G+ C-content bacteria have been described in recent years (8) . The recognition of new coryneform pathogens in laboratories is complicated by the absence of reliable commercial identification systems with in-depth databases and the heterogeneity of the organisms encountered. Recent studies have shown, however, that the use of phenotypic approaches (biochemical profiles, lipids, cell walls) and molecular taxonomic approaches (e.g., 16s rRNA sequencing) in concert (polyphasic taxonomy) provides not only a powerful means for recognizing and delineating such organisms, but also the foundation for developing improved identification schemes. In this article we report the use of a polyphasic approach to characterize a group of 10 catalase-negative, facultatively anaerobic, coryneform bacterial strains obtained from human clinical specimens, which could not be assigned to any previously established taxon. Based on the results of the present study, a new species, Actinomyces europaeus, is proposed.
MATERIALS AND METHODS
Bacterial strains. The origins of the strains studied and their clinical sources are given in Table 1 . Four strains were isolated by workers at the Department of Medical Microbiology, University of Zurich, Zurich, Switzerland, and three strains were isolated by workers at the Stichting Streeklaboratorium, Goes, The Netherlands, by standard methods (5) . The three remaining isolates were referred to the Culture Collection of the University of Goteborg, Goteborg, Sweden.
Morphological and biochemical characteristics. medium was used to assess growth in a strictly anaerobic atmosphere (10% H,, 10% CO,, 80% N,). The methods used to determine the biochemical profiles of the bacteria have been described in detail previously (5) . Using the commercial API Coryne system (bioMCrieux, Marcy l'Etoile, France), we read enzymatic reactions after 24 h of incubation at 37"C, whereas fermentation reactions were observed after 72 h of incubation. Additional enzymatic reactions were studied by using the API ZYM system (bioMtrieux). The API 50CH system (carbohydrate fermentations) was used in conjunction with 50CHE medium (both obtained from bioMCrieux), and reactions were read after 120 h of incubation at 37°C. Antimicrobial agent susceptibility tests. MICs of 24 antimicrobial agents were determined by a microdilution method; 96-well microtiter plates contained the antibiotics in lyophilized form with one starting concentration and 11 twofold dilutions (i.e., there were eight antimicrobial agents per plate) (Merlin Diagnostics, Bornheim-Hersel, Germany). A bacterial suspension (McFarland standard 05) was prepared in 0.9% NaCl, 200 pl of the suspension was transferred into 10 ml of H-medium (Merlin), and 100 pl of this preparation was added to each well of the microtiter plate. The plates were incubated in a 5% C0,-enriched atmosphere at 35°C. Bacterial growth was observed after 48 h by reading the microtiter plates with an automated Multiskan MS reader (Labsystems Oy, Helsinki, Finland) at a wavelength of 620 nm. A n emission adsorbance value of 20.130 indicated growth. All of the plates were also examined by eye for bacterial growth, but no discrepancies were observed.
MIC5[, was the MIC of an antimicrobial agent at which 50% of the isolates were inhibited, and MIC,, was the MIC at which 90% of the isolates were inhibited.
Gas-liquid chromatography. Cells were grown under anaerobic conditions in PRAS chopped meat carbohydrate broth (9) for 48 h at 37°C to determine the end products of fermentation. The detection method used has been described previously (5) . Cellular fatty acid patterns were generated by using the Sherlock Microbial Identification System (Microbial ID, Inc., Newark, Del.) (21) .
Cell wall analysis. The peptidoglycan structure was determined by the method of Schleifer and Kandler (IS), except that ascending thin-layer chromatography on cellulose sheets (Merck, Darmstadt, Germany) was used.
PAGE of whole-cell proteins. Most strains were grown on horse blood agar (Columbia base) at 37°C in the presence of 5% CO,; the only exception was Actinomyces israelii CCUG 18307T, which was grown under anaerobic conditions. Polyacrylamide gel electrophoresis (PAGE) of whole-cell proteins was performed as described previously (15) . For densitometric analysis, normalization, and interpretation of protein patterns, the Gelcompar 3.1 software package (Applied Maths, Kortrijk, Belgium) was used. Levels of correlation are presented below as percentages of similarity.
DNA base composition. DNAs were prepared and G + C contents were determined as described previously (6) . 1541 to 1522) as previously described (11) . The PCR products were purified by using a Prep-A-Gene kit (Bio-Rad, Hercules, Calif.) according to the manufacturer's instructions and were sequenced by using a Taq DyeDeoxy terminator cycle sequencing kit (Applied Biosystems, Inc., Foster City, Calif.) and a model 373A automatic sequencer (Applied Biosystems, Inc.). The sequences determined and the sequences of other high-G+C-content actinomycetes (obtained from the EMBL Data Library) were aligned by using the program PILEUP (2), Seven of the 10 clinical strains were isolated from human abscesses ( Table 1 ). In the majority of the cases the coryneform organism was the only aerobically growing bacterium, but on anaerobically incubated culture plates a mixed anaerobic flora (i.e., at least three morphologically different anaerobes) was detected. Therefore, the etiologic role of the unidentified coryneform bacterium as a pathogen remained unclear. Similar clinical sources have been reported for Arcanobacteriurn bernardiae (7), as well as for Actinornyces radingae and Actinornyces turicensis strains (13, 22, 23) .
Colonies of the strains were translucent, grayish, and less than 0.5 mm in diameter after 48 h of incubation in a 5% C0,-enriched atmosphere at 37°C. The growth rate under strictly anaerobic conditions was similar to the growth rate described above. Some strains exhibited very slight beta-hemolysis on sheep blood agar plates. Gram staining of the organisms revealed relatively short gram-positive rods with irregular morphology and no filament formation.
According to the general typing scheme for coryneform bacteria encountered in clinical specimens outlined by von Graevenitz and Funke (20), we observed the following biochemical characteristics: catalase-negative, fermentative, nonmotile rods; negative for nitrate reduction and urea hydrolysis; variable for hydrolysis of esculin; positive for fermentation of glucose and maltose but not for fermentation of mannitol and xylose; variable for fermentation of sucrose; and negative for the CAMP reaction ( Table 2 ). All of the strains produced large amounts of succinic acid as the end product of glucose fermentation. The strains were, therefore, considered members of an and the alignment was corrected manually. Distance matrices were produced by netic trees were constructed with the algorithm of Fitch and Margoliash (4) and by using the neighbor-joining method of Saitou and Nei (16) . The statistical significance of the groups obtained was assessed by bootstrapping (500 replicates) by using the programs SEQBOOT, DNADIST, NEIGHBOR, and CON-SENSE (3).
Nucleotide sequence accession number. The 16s rRNA gene sequence of strain CCUG 32789AT which we determined has been deposited in the EMBL Data Library under accession no. Y08828.
Actinomyces species. The biochemical profile study was exusing the DNADIST program Of the PHYLIP package (3). Unrooted phylogetended by using the API Coryne system. The results of the initial biochemical screening reactions were confirmed, and the organisms were tentatively designated Enevold Falsen (EF) group 43 bacteria, Arcanobacterium bemardiae-like bacteria, or CDC coryneform group E-like bacteria (10) by the different collaborators who participated in this joint project as the biochemical profile was incompatible with the profiles of previ- ously established Actinomyces species ( Table 2 ). The strains were initially designated Arcanobacterium bernardiae-like because they fermented maltose more rapidly than they fermented glucose, like Arcanobacterium bernardiae (8), and because their biochemical profile was similar to that of Arcanobacterium bemardiae (7), which ferments glycogen but not sucrose and which does not hydrolyze esculin ( Table 2 ). The unknown coryneform bacteria also phenotypically resembled CDC coryneform group E bacteria (10, 13) (i.e., Actinomyces radingae and Actinomyces turicensis [23] ) except that they did not ferment xylose (Table 2 ). If hydrolysis of esculin was positive, it was delayed (occurring only after 72 to 96 h of incubation), as was hydrolysis of gelatin (as determined by the API Coryne system), which was positive only after 5 days of incubation at 37°C. The MICs of all of the penicillins tested against the 10 new coryneform strains were very low. For amoxicillin the MIC range was 50.0625 to 0.125 pg/ml, the MIC,, was 10.0625 pg/ml, and the MIC,, was 50.0625 kg/ml; for oxacillin the MIC range was 0.25 to 1 p,g/ml, the MIC,, was 0.5 pg/ml, and the MIC,, was 1 pg/ml; for penicillin G the MIC range was 10.016 to 0.125 pg/ml, the MIC,, was 0.032 pg/ml, and the MIC,o was 0.0625 pg/ml; and for piperacillin the MIC range was 50.125 to 0.5 pg/ml, the MIC,, was 0.25 pg/ml, and the MIC,, was 0.25 pg/ml. The MICs of most cephalosporins were also very low. For cefazolin the MIC range was 10.125 to 0.5 pg/ml, the MIC,, was 50.125 pg/ml, and the MIC,, was 0.25 pg/ml; for cefoxitin the MIC range was 0.125 to 0.5 pg/ml, the MIC,, was 0.125 pg/ml, and the MIC,, was 0.25 pg/ml; and for ceftriaxone the MIC range was 10.032 to 0.25 pg/ml, the MIC,, was 0.0625 pg/ml, and the MIC,, was 0.25 pg/ml. However, the MICs of some cephalosporins were significantly higher. For cefetamet the MIC range was 8 to >64 pg/ml, the MIC,, was 32 pg/ml, and the MIC,, was >64 pg/ml; and for cefibuten the MIC range was 4 to 16 pg/ml, the MIC,,, was 8 pg/ml, and the ME,, was 8 pg/ml. For the carbapenem imipenem the MIC range was 0.125 to 0.25 pg/ml, the MIC,, was 0.125 pg/ml, and the MIC,, was 0.25 p,g/ml; and for the carbapenem meropenem the MIC range was 0.0625 to 0.125 p@ ml, the MIC,, was 0.0625 pg/ml, and the MIC,, was 0.125 pg/ml. For the macrolide erythromycin the MIC range was 10.032 to 4 pg/ml, the MIC,, was 10.032 pg/ml, and the MIC,, was 10.032 pg/ml (only strain DMMZ 1284 was resistant); and for the macrolide clarithromycin the MIC range for all of the strains was 10.032 to 2 pg/ml, the MIC,, was 50.032 pg/ml, and the MIC,, was 10.032 pg/ml. For the tetracycline doxycycline the MIC range was 0.25 to 16 pg/ml, the MIC,, was 0.5 pg/ml, and the MIC,, was 0.5 pg/ml (only strain LMG 16600 was resistant); and for tetracycline the MIC range for all of the strains was 0.5 to 32 pg/ml, the MIC,, was 1 pg/ml, and the MIC,, was 2 pg/ml. For the glycopeptide teicoplanin the MIC range was 10.0625 to 0.25 pg/ml, the MIC,, was 0.125 pg/ml, and the MIC,, was 0.25 kg/ml; and for the glycopeptide vancomycin the MIC range was 0.5 to 1 pg/ml, the MIC,, was 1 Fgjml, and the MIC,, was 1 pg/ml. For chloramphenicol the MIC range was 0.25 to 1 pg/ml, the MIC,, was 0.5 pg/ml, and the MIC,, was 1 pg/ml; for clindamycin the MIC range for all of the strains tested was 50.0156 to >32 pg/ml, the MIC,, was 0.032 pg/ml, and the MIC,, was 0.032 pg/ml (only strain DMMZ 1284 was resistant); and for rifampin the MIC range was 10.016 to 0.032 pg/ml, the MIC,, was 50.016 pg/ml, and the MIC,, was 50.016 kg/ml. For the aminoglycoside amikacin the MIC range was 4 to 16 pg/ml, the MIC,, was 8 pg/ml, and the MIC,, was 16 kg/ml; and for the aminoglycoside tobramycin the MIC range was 1 to 4 pg/ml, the MIC,, was 2 pg/ml, and the MIC,, was 4 pg/ml. Two quinolones were also tested. For ciprofloxacin the MIC range was 0.5 to 1 pg/ml, the MIC,, was 1 pg/ml, and the MIC,, was 1 pg/ml; and for ofloxacin the MIC range was 2 to 4 pg/ml, the MIC,, was 2 pg/ml, and the MIC,, was 4 pg/ml. The susceptibility pattern described above is consistent with the susceptibility patterns obtained for almost all previously described Actinomyces species (17) .
An analysis of the cellular fatty acids (CFAs) revealed that CI6:, (33% ? 2% of the total CFAs [mean * standard deviation]), C18:lw9 (22% ? 3%), and C18:, (20% * 3%) were the main CFAs. Significantly, Cl0:, (1% l%), CI2:, (1% 2 l%), and C,,:, (3% ? 1%) were also detected; these CFAs are indicators that the strains should be assigned to the genus Actinomyces or the genus Arcanobacterium (1). The CFA profiles of the new coryneform bacterium both qualitatively and quantitatively matched the CFA profiles of CDC coryneform group E strains as reported by Bernard et al. (1) . An analysis of partial peptidoglycan hydrolysates revealed that the murein type was the L-lysine-L-lysine-D-glutamic acid type (type A h ) , as has been described for Actinomyces neuii and Arcanobacterium haemolyticum (21a). The G + C contents of four representative strains of the previously undescribed coryneform bacterium were found to be 61 to 63 mol% values which are within the range of values obtained for members of the genus Actinomyces (17) . The whole-cell protein profiles of 7 of the 10 strains listed in Table 1 were examined by sodium dodecyl sulfate-PAGE. A dendrogram derived from a numerical analysis of the protein profiles is shown in Fig. 1 . All seven strains grouped together and formed a distinct branch with a within-group correlation level of more than 80%. This indicated that the strains examined represent a homogeneous group and that they are distinct from all other Actinomyces and Arcanobacterium species examined.
To investigate the genetic relationships of the new coryneform bacterium, the genes encoding the 16s rRNAs of six strains were amplified by PCR and subjected to a sequence analysis. The almost complete 16s rRNA gene sequences of two strains (DMMZ 1113 and CCUG 32789AT) were determined. Each sequence consisted of approximately 1,430 nucleotides, and only a single base difference was found between the two strains (level of sequence similarity, >99.9%). Comparative sequence searches of the EMBL and GenBank libraries by using the FASTA program (2) revealed that the newly determined sequences were most closely related to sequences of species belonging to the genus Actinomyces (data not shown). The sequence of strain CCUG 32789AT was subjected to a pairwise analysis with the sequences of Actinomyces spp. and some close relatives, and derived evolutionary distances were used to determine phylogenetic relationships. A tree depicting the phylogenetic position of strain CCUG 32789AT within the genus Actinomyces is shown in Fig. 2 , and the levels of sequence similarity between the new Actinomyces species and other Actinomyces spp. are shown in Table 3 . The new organism formed a relatively long line and did not exhibit close affinity with any previously recognized Actinomyces species. The sequence divergence values (Table 3) , with the closest relative exhibiting <92% 16s rRNA gene homology, clearly demonstrated (19) that the new strain represents a hitherto unknown subline within the genus Actinomyces. To determine whether the sequences of strains CCUG 32789AT and DMMZ 11 13 were characteristic of the group of isolates, partial sequences of four other strains (DMMZ 747, DMMZ 1284, CCUG 33355, and CCUG 34687) were determined. were sequenced, and the strains were found to be genealogically very homogeneous (zero to two differences were found).
The results of both phenotypic and phylogenetic studies demonstrate that the EF group 43 bacteria (Arcanobacterium bernardiae-like bacteria, CDC coryneform group E-like bacteria) described above constitute a new species. Phylogenetically, the new species forms a long isolated line within the genus Actinomyces. Pascual Ramos et al. (14) recently conducted a detailed comparative 16s rRNA analysis of Actinomyces spp. and showed that the genus Actinomyces (as presently defined) is not monophyletic. Both sequence divergence and tree topology considerations indicate that the genus Actinomyces is in urgent need of taxonomic revision and should be subdivided into several genera (14) . Assignment of the EF group 43 bacteria to the genus Actinomyces is the most appropriate assignment at present, although we recognize that in the future this assignment may require emendation as the taxonomy of the genus Actinomyces is revised. Based on the results of the present findings, we propose that the EF group 43 bacteria (Arcanobacterium bernardiae-like bacteria, CDC coryneform group E-like bacteria) described above should be classified in a new species of the genus Actinomyces, for which we propose the name Actinomyces europaeus.
Description of Actinomyces europaeus sp. nov. Actinomyces europaeus (eu.ro.pae'us. L. adj. europaeus, European, referring to the fact that six different European laboratories contributed to this study). The following description is based on the results of a study of 10 strains.
Cells are short (length, 0.5 to 1. amygdalin, arbutin, salicin, lactose, inulin, D-raffinose, P-gentiobiose, and 2-ketogluconate. Nitrate is not reduced to nitrite. Urea is not hydrolyzed, and esculin hydrolysis is variable. P-Galactosidase, a-glucosidase, esterase, esterase-lipase, leucine arylamidase, valine arylamidase, and a-galactosidase activities are present, whereas pyrazinamidase, pyrrolidonyl arylamidase, P-glucuronidase, N-acetyl-glucosaminidase, alkaline phosphatase, trypsin, chymotrypsin, P-glucosidase, and a-mannosidase activities are not detected. Succinic acid is the main end product of fermentation. Palmitic and stearic acids are the main straight-chain cellular fatty acids, while oleic acid is the predominant unsaturated fatty acid. The interpeptide bridge in the peptidoglycan is L-lysine-L-lysine-D-glutamic acid (type A h ) . The DNA base composition is 61 to 63 mol% G+C. Strains are isolated mainly from human abscesses. The habitat of the strains is unknown. Type strain CCUG 32789A has been deposited in Culture Collection of the University of Goteborg, Goteborg, Sweden. The type strain has the characteristics described above for the species. It does not hydrolyze esculin and does not ferment sucrose. The G+C content of the type strain is 62 mol%.
